Revenue surged 36%, but profit halved—the margin squeeze that forced guidance cuts
Strong volume growth and top-line momentum masked severe margin compression. Cost inflation outpaced price pass-through, collapsing profit 48% despite 36% revenue growth. Management reset guidance on both revenue (₹1,300+ Cr from ₹1,400–1,500 Cr) and EBITDA margins (16–18% from 18–20%), signaling a longer recovery than initially guided.
₹303.8 Cr
+36% YoY
₹6.2 Cr
−48% YoY
13.2%
flat YoY; 500+ bps below FY27 guidance
42.9K MT
+35% YoY
Kuantum's Q1 reads as a study in muted gains masked by a critical weakness: revenue jumped 36% and volume surged 35%, yet profit collapsed 48%. The disconnect is cost. Inflation of ₹4,200 per ton was only 81% passed through to customers as ₹3,400 per ton in higher realizations, leaving a ₹800 per ton margin squeeze. Management's response was to cut full-year guidance on both revenue (now ₹1,300+ Cr from ₹1,400–1,500 Cr) and EBITDA margins (16–18% from 18–20%), citing West Asia cost spikes and local raw-material pressures. The market repriced immediately: a 7% day-1 drop reflected the guidance miss and deteriorating credibility.
Where the profit went
Of the ₹4.2K/ton cost surge in Q1, roughly 50% came from West Asia (fuel/chemicals driven by geopolitical tensions); the rest from local sourcing pressures in Punjab. Kuantum passed 81% through to customers — a respectable achievement in a commodity cycle but insufficient to protect margin. Net selling realization (NSR) rose ₹3.4K/ton quarter-over-quarter, but only ₹4K/ton year-over-year (7% growth), undershooting the trajectory needed to offset inflation and drive the prior 18–20% EBITDA target. The margin math is unforgiving: revenue growth alone does not recover profit when cost inflation outpaces price leverage.
35% volume growth, higher NSR in core markets
SUPPORTED42.9K MT (+35% YoY), NSR up ₹4K/ton Y-o-Y. But QoQ NSR up only ₹3.4K/ton vs ₹4.2K/ton cost inflation — net margin erosion.
EBITDA margin 13.2%, broadly stable YoY
CONTRADICTEDQ1 delivered 13.2% OPM; prior 18–20% target path suggests margins should expand, not stagnate. Current 13.2% is 500+ bps below year-end guidance.
FY27 revenue ₹1,400–1,500 Cr guidance maintained
OVERSTATEDRevised to ₹1,300+ Cr (−₹100–200 Cr). Management cited lower price realization than expected and West Asia pressures.
Specialty paper +20% EBITDA lift; 5–6% price realization target
PARTIALSpecialty at 18–19% of mix, targeting 30% by FY28–29. Incremental realization 5–6% claimed but not yet achieved. Ramp slower than guided.
Cost inflation of ₹4.2K/ton offset by ₹3.4K/ton NSR gain
CONTRADICTEDNet compression of ₹800/ton. Pass-through was 81%, not 100%. Margins compressed QoQ despite top-line growth YoY.
What changed on this call
This is the third mid-year guidance reset in Kuantum's recent story. From the FY26 earnings calls, management had projected ₹1,600–1,700 Cr revenue and 18–20% EBITDA margins by FY28. That target has now been pushed back conservatively to ₹1,500–1,650 Cr by FY28–29, with EBITDA margins reset to 16–18% (not 18–20%). For FY27 itself, the ₹1,400–1,500 Cr guidance is now ₹1,300+ Cr — a material miss. The signal is unambiguous: management's visibility into cost trends and pricing power has deteriorated faster than expected, and they are now hedging guidance to rebuild credibility.
The bull-bear ledger
Volume +35%, capacity expansion on track (PM3 online by Aug 2026)
Specialty paper ramp (18–19% to 30% target) offers 20% EBITDA uplift if achieved
AI cost optimization targeting 4–5% opex reduction by FY28
Debt reduction ₹170–175 Cr/year over 3 years; path to <₹300 Cr by FY29
PAT collapsed 48% YoY despite +36% revenue growth — margin compression across the board
Guidance cuts on revenue and EBITDA margin; poor visibility ahead signals execution risk
Debt burden ₹760 Cr peak; interest cost ₹60–70 Cr/year consumes ₹6.2 Cr quarterly PAT
Specialty ramp executing slowly (18–19% vs 30% target); timeline extended to FY28–29
Commodity pricing remains soft; pricing power limited by imports despite antidumping filings
Margin compression from cost inflation
HIGHWest Asia conflict-driven fuel/chemical spikes, plus local wheat straw inflation. Of ₹4.2K/ton cost rise, only ₹3.4K/ton passed through. Until commodity costs stabilize globally and locally, margin recovery is stalled. Q1 proved prices cannot absorb the full inflation.
Debt burden constrains returns and flexibility
HIGH₹760 Cr peak debt, ₹60–70 Cr annual interest. Q1 PAT ₹6.2 Cr insufficient to cover debt service + capex repayment. Debt reduction ₹170 Cr/year is necessary but aggressive. Any miss on EBITDA means interest coverage deteriorates and refinancing risk rises.
Pricing power erosion in commodity segments
HIGHPaper is commodity; imports from China/Indonesia set pricing floor despite antidumping filings. Writing/printing segment (80% of revenue) facing 1–3% CAGR demand headwinds. NSR ₹68–69K/ton vs aspiration ₹72–75K/ton — the gap is widening, not narrowing.
Execution lag on capacity and specialty paper ramp
MEDIUMPM3 rebuild on track for Aug 2026, but environmental clearance (EC) delayed — red flag. Specialty ramp at 18–19% vs 30% target; slow to date. Full capacity ₹1,500–1,650 Cr assumes 330 working days/year; actual utilization may fall short if demand remains weak.
Regulatory and structural headwinds (inverted GST, tariffs)
MEDIUMMaplitho segment hit by inverted GST post-rate change; company reducing footprint. ADD (antidumping duty) case filed but approval uncertain; 5-year protection timeline unconfirmed. Environmental clearances delaying PM3 EC. Policy shifts can accelerate margin deterioration without warning.
How the market is positioned
The stock fell 7% on day 1 (from ₹86 to near ₹80) — a decisive repricing that suggests the guidance miss was not priced in before the result. It has stabilized around ₹80.95, now 27% below its all-time high of ₹111.3 and trading above its 20-day moving average (₹80.33) but below the 200-day (₹85.18), signaling an intact downtrend. Foreign institutional investors have nearly exited (0.04% holding, down from 0.09% a year ago), while domestic institutions are absent (0.01%). Promoters hold steady at 70.30%, showing no insider selling — a small positive that suggests they still believe in the long-term story, though the near-term is clearly under pressure. The relative inaction from FII/DII suggests institutional skepticism on the near-term recovery narrative, but the 27% drawdown may be attracting value hunters who believe in the PM3 commissioning and specialty ramp stories.
What to watch next
1 · PM3 commissioning (within August 2026)
Full-capacity operation (4 machines online) is the linchpin for revenue and EBITDA margin recovery to guidance. Delayed EC (environment) clearance is a red flag; execution by month-end will signal management credibility on timelines. Delays beyond August push FY27 margin targets further out.
2 · Q3 FY27 EBITDA margin trajectory (Oct–Dec 2026)
Post-PM3, management targets 16–18% EBITDA margin visibility by Q3. If margins remain flat at 13–14% or compress further, the long-term 18–20% target becomes unrealistic and debt servicing risk rises sharply. Margin improvement is the single best indicator of whether the business is stabilizing.
3 · Specialty paper ramp pace (FY28 results)
Currently 18–19% of revenue mix, targeting 30% by FY28–29. If specialty share accelerates to 25%+, the +20% EBITDA uplift becomes credible. If stuck <25% at FY28 year-end, specialty strategy is in doubt and margin recovery timeline extends further — likely bad for the stock.
4 · Anti-dumping duty (ADD) approval timeline
5-year tariff protection on writing/printing paper (40–140 GSM) filed with Indian government; approval timeline uncertain. If granted by end-FY27, pricing floor improves meaningfully. If rejected or delayed past FY28, import competition will intensify and pricing power erodes.
5 · Debt reduction trajectory vs ₹170 Cr/year commitment
Management committed to ₹170–175 Cr annual repayment starting FY27. If leverage drops faster than expected (debt/EBITDA <3.0x by FY28), interest burden eases and PAT flexibility improves. If deleveraging stalls due to EBITDA shortfalls, refinancing risk and equity pressure rises.
Kuantum's story is a steady-state reset, not a step-change. The company has real volume growth, genuine capacity expansion coming online (PM3), and a credible multi-year roadmap (specialty paper, AI cost cuts, debt reduction). But Q1's 48% PAT collapse despite 36% revenue growth exposes the fragility of that roadmap: margin recovery depends entirely on commodity costs stabilizing and specialty paper scaling faster than execution has shown to date.
The debt burden of ₹760 Cr is the shadow issue — it consumes too much of the profit pie, leaving little room for shareholders even if margins recover to target. The ₹60–70 Cr annual interest cost alone is 10× the current quarterly PAT. Management's credibility has been strained by two mid-year guidance cuts; they now need to deliver tangibly on PM3 commissioning by August and Q3 margin improvement to rebuild confidence.
For holders, the single number to track is organic EBITDA margin (core operations, ex-one-time other income). If Q2/Q3 push toward 16–18% guidance, the bull case gains real traction and the 27% drawdown looks like an opportunity. If margins stagnate at 13–14%, debt risk rises materially and the stock likely tests ₹65–70. The next two quarters will tell whether Kuantum is a credible capacity story or a broken-guidance stock.
Revenue surges 36%, but PAT halved—margin squeeze amid cost wars
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Revised FY27 revenue and EBITDA guidance downward Q1 call. Prior 18–20% margin target now 16–18%.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Revenue momentum is real (+36% YoY, +35% volume) but masked by severe margin compression. PAT collapsed 48% YoY despite top-line strength. Management cut FY27 guidance (₹1,300+ from ₹1,400–1,500 Cr; 16–18% EBITDA from 18–20%), citing West Asia cost spikes and local raw-material inflation. Debt burden (₹760 Cr peak) consumes profits; execution risk on specialty paper ramp and capacity utilization.
₹303.8 Cr
Revenue · +36.3% YoY₹6.2 Cr
Reported PAT · −48.3% YoYCompressing
Margins · vs guidance: OverstatedDid the claims hold up?
35% volume growth, higher NSR in markets
METVolume +35% to 42,922 MT, NSR up ₹3,400/ton QoQ supported claim
EBITDA margin 13.2%, broadly stable YoY
MISSDelivered 13.2% OPM but NPM only 2.0%; YoY EBITDA flat contradicts prior 18–20% target path
FY27 revenue ₹1,400–1,500 Cr guidance maintained
OVERSTATEDRevised to ₹1,300 Cr+ citing West Asia, lower realizations, and cost pressure
Specialty paper +20% EBITDA, 5–6% price lift target
PartialSpecialty at 18–19%, targeting 30%; incremental realization 5–6%, not yet achieved
Cost of ₹4,200/ton increase offset by ₹3,400/ton NSR gain
MISSNet margin compression ₹800/ton QoQ; ~50% of cost increase from West Asia conflict
Earnings quality
What changed since the last call
FY27 revenue guidance revised down
DowngradePrior ₹1,400–1,500 Cr, now ₹1,300+ Cr (−₹100–200 Cr). Reason: lower price realization than expected, West Asia cost inflation persisting
EBITDA margin target lowered
DowngradePrior 18–20% target by year-end, now 16–18%. West Asia conflict, wheat straw cost pressures, limited price pass-through
Long-term revenue reset conservatively
DowngradeFY28–29 peak at ₹1,500–1,650 Cr (vs prior ₹1,600–1,700 Cr FY28), citing commodity cycle extended downturn and margin recovery slower
Specialty paper target extended
NeutralStill targeting 30% by FY28–29 (18–19% currently), but timeline pushed. Incremental realization 5–6%, not yet achieved
The Q&A
Analysts pressed hard on guidance miss (Arjun Tambe: ₹1,300 vs ₹1,500 gap). Pavan acknowledged cost inflation, lower realizations, but deflected to external shock (West Asia). On pricing, Anu Parakh questioned flat Y-o-Y realization despite 11% BHKP rise; management pushed back claiming 7% NSR growth Y-o-Y, not flat. Mixed credibility.
Guidance and margins — Jiten Parmar, Aurum Capital
PartialGuidance is positive; EBITDA margins targeting 16–18% by year-end (now commissioned PM3 online). Previous 18–20% now 16–18%.
Debt and deleveraging — Jiten Parmar, Aurum Capital
AnsweredPeak ₹760–770 Cr, repayments ₹170–175 Cr/year next 2–3 years, to <₹300 Cr by end of 3 years.
Raw material sourcing — Jiten Parmar, Aurum Capital
Answered50–50 split; sourcing within Punjab/neighboring states, no availability issues.
Import competition — Jiten Parmar, Aurum Capital
AnsweredDiminishing imports due to logistics/shipping costs, pricing stable. No major competition expected.
Cost pass-through — Madhav Jhawar, SKP Securities
PartialTargeting +20% EBITDA on specialty; 5–6% initial realization uplift from specialty grades.
Raw material cost trends — Madhav Jhawar, SKP Securities
AnsweredPrices higher than Q4, stabilized at current levels, no further rise expected. Wheat straw coming down Q2 vs Q1.
Debt burden concern — Rajesh Bhandari, Nakoda Engineers
PartialFY26–27 repayment ₹170 Cr, by 3 years debt to ₹300–350 Cr. Growth capex necessary; investments must fruit before profit retained.
Price realization — Anu Parakh, Anand Rathi
AnsweredNSR up ₹4,000/ton Y-o-Y (7% growth), not flat. Current ₹68–69K/ton targeting ₹72–75K/ton next 4–6 months.
Maplitho GST impact — Anu Parakh, Anand Rathi
AnsweredReducing notebook paper production; minimizing impact. Passed GST loss to customers; no real complexity.
ADD applications — Anu Parakh, Anand Rathi
AnsweredAlready filed ADD and anti-subsidy applications; coordinating with govt, hopeful of favorable outcome.
Volume growth Q1 — Apurva Anil Sharma, RAAS Capital
PartialQ1 prior year had machine shutdown; Q1 FY27 vs Q4 FY26 production slightly up due to machine efficiency gains.
ADD coverage — Apurva Anil Sharma, RAAS Capital
AnsweredYes, filing is on writing/printing paper segment, covers all GSM 40–140 Kuantum produces; 5-year protection expected.
Guidance revision gap — Arjun Vinay Tambe, Aurrevia Crest
DodgedPrior guidance assumed higher realizations; those are running below expectations. EBITDA margins strained by West Asia crisis, operational cost inflation. Conservative figures now.
AI integration timeline — Arjun Vinay Tambe, Aurrevia Crest
AnsweredYes, continuous process; targeting 4–5% cost reduction by March 2028.
Specialty paper contribution — Arjun Vinay Tambe, Aurrevia Crest
PartialWorking towards 30% target; currently 18–19% but efforts underway.
EBITDA margin lag vs peers — Arjun Vinay Tambe, Aurrevia Crest
PartialWest Asia impacted all; our location in Punjab faces abnormally high raw material cost pressures locally. Gradual cost reduction underway.
Peak capacity turnover — Moksh Ranka, Aurum Capital
AnsweredCurrent: ₹1,400–1,500 Cr; FY23 realizations: >₹1,800 Cr (all 4 plants at peak capacity).
Full capacity timeline — Moksh Ranka, Aurum Capital
AnsweredYes, post PM3 commissioning within this month, all plants running at peak.
Other income detail — Shayan Khan, Individual Investor
AnsweredPrimarily plant and scrap sales. Operational related; adds to reported EBITDA margin (14.4% ex-one-time).
Medium-term revenue outlook — Arjun Vinay Tambe, Aurrevia Crest
PartialConservative ₹1,500 Cr; if pricing improves to ₹75K/ton could reach ₹1,600–1,650 Cr.
Cost vs margin recovery — Arjun Vinay Tambe, Aurrevia Crest
AnsweredInput costs rising, not bottomed. Pricing has bottomed; expecting uptrends on margin recovery.
Cost inflation pass-through — Rohan Choksi, RAAS Capital
Answered~50% from West Asia conflict; rest local sourcing. Out of ₹4,200, ₹3,400 passed on via price increase Q-o-Q.
Peak capacity revenue vs 100% assumption — Rohan Choksi, RAAS Capital
AnsweredPeak capacity at 100% paper machines operate ~330 days/year (35 days downtime). GSM mix also impacts output. ₹1,500–1,650 Cr is realistic.
Specialty segment strategy — Rohan Choksi, RAAS Capital
PartialIncreasing specialty 5% annually, targeting 30%. But writing/printing legacy market strong; cannot abandon it overnight.
Wheat straw price trends — Anant Mundra, Mytemple Capital
AnsweredYes, coming down. Q2 vs Q1 seeing reduction in procurement prices.
Pulp capacity increase — Utkarsh Nopany, Anand Rathi
AnsweredPulp capacity increasing to 410–415 TPD. Filler ~150–180 TPD, imported pulp 40–50 TPD for product quality.
Q2 pricing trend — Utkarsh Nopany, Anand Rathi
AnsweredQ2 is leanest quarter, but pricing remained stable; no downward impact on our products.
Imported paper pricing — Utkarsh Nopany, Anand Rathi
Answered$610–$620/ton; volumes not large enough to create negative impact.
Timber price outlook — Utkarsh Nopany, Anand Rathi
AnsweredPositive trend, stable or reducing 5–6%. Medium-term stable as rising labor/transport offset any base price decline.
Paper inventory in channel — Utkarsh Nopany, Anand Rathi
AnsweredSlack in inventory; pipelines relatively empty. Suggests demand surge coming, likely positive for pricing.
Specialty seedling sales (P29, E2) — Arjun Vinay Tambe, Aurrevia Crest
PartialHigh-yielding, high-growth varieties; encouraging offtake trend. Target 40 lakh → 1 crore saplings/year in 3–4 years.
Seedling as revenue stream — Arjun Vinay Tambe, Aurrevia Crest (follow-up)
AnsweredCSO clarified: not pure revenue play. Goal is reduce wood procurement cost. Future sustainability exercise when supply increases, will lower wood cost.
Guidance
FY27 ₹1,300 Cr+ (revised from ₹1,400–1,500 Cr)
MediumDriven by lower price realization than expected + West Asia cost pressures. Q1 delivered ₹304 Cr (~annualized ₹1,216 Cr base case); guidance implies acceleration H2.
FY28–29 ₹1,500–1,650 Cr at peak capacity (prior ₹1,600–1,700 Cr FY28)
MediumDepends on pricing recovery from commodity low. Specialty ramp, AI cost cuts, full 4-machine operation assumed.
FY27 EBITDA 16–18% by year-end (prior 18–20% target)
MediumQ1 achieved 13.2%, guidance implies 300–500 bps improvement via raw material cost stabilization + specialty mix improvement + operational efficiency.
FY28–29 18–20% EBITDA margin at peak capacity
LowDependent on commodity pricing recovery + successful specialty ramp + AI opex cuts 4–5%; West Asia conflict persistence is downside risk.
Major capex cycle completion within FY27 (PM3 Aug 2026)
HighPM3 rebuild/commissioning on track; pulp capacity to 410–415 TPD. No major capex post-FY27.
Risks the call surfaced
Margin compression
HighQ1 cost inflation ₹4.2K/ton only 81% passed (₹3.4K/ton), net margin squeeze ₹0.8K/ton. Specialty ramp (18–19% mix) insufficient to offset bulk paper pricing pressure.
Debt burden
HighPeak debt ₹760–770 Cr, annualized interest >₹60–70 Cr consumes PAT; ₹6.2 Cr Q1 PAT insufficient to service debt + repay ₹175 Cr/year. Default risk low but leverage constrains returns.
Pricing power erosion
HighPaper is commodity; import competition from China (despite antidumping efforts). Writing/printing segment seeing 1–3% CAGR demand; realization ₹68–69K/ton vs ₹75K+ aspirational. Limited ability to raise prices without volume loss.
Execution risk on capacity/specialization
MediumPM3 rebuild on track for Aug 2026, but EC clearance still pending. Specialty paper 18–19% mix vs 30% target; ramp slower than guided. Peak capacity ₹1,500–1,650 Cr revenue assumes 330 working days, specific GSM mix; actual utilization may fall short.
Regulatory/tariff risk
MediumMaplitho segment hit by inverted GST post-rate change; company reducing footprint but impact still material. ADD case filed but approval uncertain; 5-year horizon. EC clearance for PM3 delayed.
Management
Score 6/10. Moderate transparency; deflects on pricing realization and guidance miss. Acknowledges West Asia crisis but vague on local cost inflation root causes. Candid on debt burden and capex reset. Mixed track record: Capex initiatives (DDS, starch system, Folio wrapping) on track. But prior FY27 guidance (₹1,400–1,500 Cr) now ₹1,300+; EBITDA 18–20% now 16–18%. Specialty paper ramp slow (18–19% vs 30% target). Debt not reducing as fast as prior commitment.
1 · Aug 2026 (within month)
PM3 machine commissioning → 4 machines online, full capacity production
2 · Q3 FY27
Operations at full efficiency post-maintenance; EBITDA 16–18% target expected visible
3 · Sep–Oct 2026
Wheat straw seasonal decline reduces local raw-material cost; Q2 already seeing relief
Debt burden (₹760 Cr peak) consumes profits; execution risk on specialty paper ramp and capacity utilization.
Kuantum Papers Q1 FY27: standalone PAT falls 48% YoY to ₹6.2 Cr despite 36% revenue growth
PAT -48.34% YoY · revenue +36.26% · margins compressing
₹303.75 Cr
+36.26% YoY
₹6.23 Cr
-48.34% YoY
2.03%
-3.4pp YoY
₹0.71
Kuantum Papers' standalone Q1 FY27 (quarter ended June 30, 2026) print is a margin story, not a growth one. Revenue from operations rose 36.3% YoY to ₹303.75 Cr (₹222.92 Cr in Q1 FY26) — though almost flat sequentially at +0.9% versus ₹300.94 Cr in Q4 FY26 — while standalone PAT fell 48.3% YoY to ₹6.23 Cr (₹12.06 Cr a year ago) and 56.6% QoQ (₹14.34 Cr). PBT dropped 33.7% YoY to ₹10.77 Cr. No consolidated figures exist since the company has no subsidiaries or JVs, so standalone is the only and primary basis.
Q1 FY-2027 vs prior quarters
The compression sits almost entirely on the cost side. Cost of materials consumed jumped 71.2% YoY to ₹129.34 Cr, cost of chemicals consumed rose 43.5% YoY to ₹60.35 Cr, and power & fuel expense climbed 44.8% YoY to ₹41.95 Cr — all comfortably outpacing the 36% revenue increase. Finance costs added further drag, up 39.9% YoY to ₹14.53 Cr. Net result: net profit margin fell to roughly 2.1% of revenue from 5.4% YoY (4.8% QoQ), and EBITDA margin (PBT + finance costs + depreciation, over revenue) slid to about 14.1% from roughly 18.1% YoY and 15.9-16.3% QoQ — a clear margin-trend reversal after a stronger Q4.
The stock went into the print at ₹84.25, up 9.6% over the past month of trading.
For context: revenue is at a 6-quarter high.
What the summary numbers don't show
Basic EPS ₹0.71, down from ₹1.38 YoY and ₹1.64 QoQ.
Management provided a positive outlook for the next 2-3 years, projecting a turnover in the range of INR 1,600 to 1,700 crores and EBITDA margins between 18% to 20%. They anticipate a significant increase in manufacturing and selling volumes to approximately 2,30,000 tons annually, a 40-50% growth. The company expects
— This quarter: missed
Management's own FY27 outlook, reiterated after Q4 FY26 results, projected full-year revenue of ₹1,400-1,500 Cr and an 18-20% EBITDA margin, with analysts penciling in 15-20% FY27 PAT growth; industry commentary at the time also flagged a pricing recovery from reduced dumping heading into Q1 FY27 (The Pulp and Paper Times). Against that, Q1's ~14.1% EBITDA margin and a YoY PAT decline sit below where the guided trajectory implies the year should be tracking, even allowing for one quarter out of four. No brokerage-specific PAT estimate for this exact quarter turned up in search, so vsStreet is marked unknown rather than guessed. The company disclosed no management press release beyond the filing itself, so there is no additional framing to reconcile.
W1
FY27 guidance calls for ₹1,400-1,500 Cr revenue and 18-20% EBITDA margin — Q1's ~14.1% margin needs sharp recovery over the next three quarters to stay on track.
W2
Paper Machine-3 upgrade completion and its effect on volumes and per-unit costs once fully back online.
W3
Use and impact of the ₹100 Cr NCD raise — whether it funds capex or working capital, and its effect on finance costs given they already rose 39.9% YoY.
Standalone only — company has no subsidiaries/JVs so consolidated results are not applicable (per Note 5 of the filing). No exceptional items disclosed. Entire Q1 tax charge (₹4.54 Cr) is deferred tax; current tax was nil vs ₹0.70 Cr in Q1 FY26.